Cas:89797-00-2 5-[acetyl-(2-hydroxy-3-methoxypropyl)amino]-1-N,3-N-bis(2,3-dihydroxypropyl)-2,4,6-triiodobenzene-1,3-dicarboxamide manufacturer & supplier

We serve Chemical Name:5-[acetyl-(2-hydroxy-3-methoxypropyl)amino]-1-N,3-N-bis(2,3-dihydroxypropyl)-2,4,6-triiodobenzene-1,3-dicarboxamide CAS:89797-00-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

5-[acetyl-(2-hydroxy-3-methoxypropyl)amino]-1-N,3-N-bis(2,3-dihydroxypropyl)-2,4,6-triiodobenzene-1,3-dicarboxamide

Chemical Name:5-[acetyl-(2-hydroxy-3-methoxypropyl)amino]-1-N,3-N-bis(2,3-dihydroxypropyl)-2,4,6-triiodobenzene-1,3-dicarboxamide
CAS.NO:89797-00-2
Synonyms:IOPENTOL;UNII-7D6XWX076T;Iopentolum;Imagopaque
Molecular Formula:C20H28I3N3O9
Molecular Weight:835.16400
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:858.8ºC at 760 mmHg
Density:2.095g/cm3
Index of Refraction:1.693
PSA:195.87000
Exact Mass:834.89600
LogP:0.17620

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:NONH for all modes of transpor
Packing Group:


Contact us for information like IOPENTOL chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Imagopaque physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Iopentolum Use and application,Imagopaque technical grade,usp/ep/jp grade.


Related News: Soliris, first approved for generalized myasthenia gravis (gMG) in 2017, carries a list price of about $470,000 annually. But to ICER, that cost is “well beyond typical thresholds.” (Z)-4-oxo-4-(2-prop-2-enoyloxyethoxy)but-2-enoic acid manufacturers The superiority to psilocybin is due in part to the incorporation of a conjugated amplification moiety (CAM) that enhances 5-HT2A specific effects while reducing non-specific effects. N-(1-cyanocyclopentyl)-2-fluorobenzamide suppliers For these reasons, many pharmaceutical companies are choosing to evaluate biocatalytic processes during early-stage drug development to avoid missing opportunities for capitalizing on these gains. [5-[(2-methylpropan-2-yl)oxycarbonyl]thiophen-2-yl]boronic acid vendor & factory.